The India Cataract Surgery Devices market has a long and transformative history that reflects the country’s journey from mass blindness eradication drives to advanced vision restoration technologies. In the early decades, cataract surgeries were primarily performed under government-led blindness control programs using manual techniques such as intracapsular and extracapsular extraction. The National Programme for Control of Blindness (NPCB), launched in 1976, played a vital role in improving accessibility, creating awareness, and building surgical infrastructure in both rural and urban India. The demand for cataract surgery devices in India is fueled by several factors, including rising incidences of cataract-related blindness, increasing awareness about modern surgical options, and the rapid expansion of eye care facilities across tier-2 and tier-3 cities. The growing adoption of advanced technologies like femtosecond laser-assisted cataract surgery, premium multifocal and toric IOLs, and the availability of disposable microsurgical instruments has further expanded the market’s value. From a regulatory and certification perspective, cataract surgery devices in India fall under the purview of the Central Drugs Standard Control Organisation (CDSCO).

Nonetheless, India’s “Make in India” initiative and supportive policies for medical device manufacturing have encouraged local production, improving self-reliance and innovation in ophthalmic technology.According to the research report "India Cataract Surgery Devices Market Research Report, 2030," published by Actual Market Research, the India Cataract Surgery Devices market is anticipated to grow at 7.58% CAGR from 2025 to 2030. Local manufacturing of standard IOLs and consumables has made cataract surgeries more affordable, while international players continue to introduce high-end, premium devices. India has also emerged as a major destination for medical tourism in ophthalmology, with patients from neighboring countries and the Middle East seeking high-quality yet cost-effective surgical solutions. In rural India, non-profit organizations and CSR initiatives collaborate with government schemes to conduct free eye camps and screening drives, often sponsored by device manufacturers as part of their social responsibility efforts. Such marketing strategies not only boost brand awareness but also help bridge the urban–rural divide in eye healthcare access. Manufacturers and importers must comply with stringent standards, including quality certifications like ISO 13485, and ensure proper device registration and labeling. These regulatory frameworks ensure product safety, efficacy, and traceability, although they can pose challenges for smaller domestic firms due to cost and documentation requirements.

Domestic manufacturers are also playing an essential role in driving affordability and accessibility. India has developed a strong base for producing standard IOLs, viscoelastics, and disposable surgical instruments at competitive prices, making the country a hub for cost-effective ophthalmic devices. Furthermore, collaborations between global companies and Indian manufacturers under initiatives like “Make in India” are helping transfer advanced technology while ensuring that devices meet international safety and quality standards.Intra-ocular lenses (IOLs) dominate the Indian market, accounting for the majority of device usage in cataract procedures. The country witnesses a very high surgical volume due to the large elderly population and government programs such as the National Programme for Control of Blindness and Visual Impairment (NPCBVI), which have made cataract surgeries widely available, even in rural and low-income areas. The demand for IOLs spans both economic and premium segments public hospitals and non-governmental organizations primarily use standard monofocal IOLs for cost-effective, large-scale surgeries, while private hospitals and urban eye-care centers increasingly offer advanced options such as multifocal, toric, and aspheric lenses for patients seeking improved visual outcomes. India has also become a hub for domestic IOL manufacturing, with local players offering affordable, high-quality products that compete successfully against imported brands.

Phacoemulsification systems form a key part of the surgical landscape, with growing adoption across both public and private sectors. While manual small-incision cataract surgery (MSICS) remains common in rural hospitals due to its low cost and simplicity, the shift toward phacoemulsification continues as more surgeons are trained in modern techniques and as patient awareness rises regarding faster recovery and better visual results. Ophthalmic viscoelastic devices (OVDs) are indispensable in every cataract operation, supporting lens implantation and corneal protection, with demand closely tied to surgical volumes. Femtosecond laser systems represent a small but emerging niche, primarily concentrated in premium urban eye hospitals that cater to affluent patients and medical tourists seeking laser-assisted cataract surgery.Hospitals and eye-care institutions dominate India’s cataract surgery devices market, with both public and private sectors playing crucial roles in driving surgical volumes. Public hospitals, medical colleges, and district health centers perform the majority of cataract surgeries under national blindness control programs, often supported by NGOs and charitable foundations. These facilities typically rely on cost-effective phaco systems, standard IOLs, and locally manufactured OVDs to maintain affordability while reaching underserved populations.

The government’s partnerships with non-profit organizations have enabled millions of free or subsidized cataract surgeries annually, especially in rural areas. At the same time, private hospitals and specialized eye-care chains such as Dr. Agarwal’s Eye Hospital, Sankara Nethralaya, LV Prasad Eye Institute, and Centre for Sight are transforming the market by emphasizing quality, technology, and patient comfort. These institutions invest heavily in advanced phacoemulsification platforms, premium IOLs, and femtosecond laser systems, appealing to middle- and upper-income patients who value precision and premium vision correction. Ambulatory surgery centers (ASCs) and standalone ophthalmology clinics are also growing rapidly in tier-1 and tier-2 cities, focusing on high-efficiency outpatient cataract procedures with reduced recovery times and competitive pricing. These facilities often partner with diagnostic centers for preoperative testing and offer customized surgical packages to attract diverse patient groups.

Furthermore, India’s expanding medical tourism industry adds to demand for advanced cataract technologies, as international patients seek high-quality, affordable eye care.Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cataract Surgery Devices Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• Intra-ocular Lenses (IOL)• Phacoemulsification Systems• Ophthalmic Viscoelastic Devices• Femtosecond Laser Systems• Others (Knives and Low-Cost Consumables)By End User• Hospitals• Ambulatory Surgery Centers• Ophthalmology Clinics• Academic and Research Institutes.